- Home
- SKT vs CORT Comparison
SKT vs CORT Comparison
Compare SKT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKT | CORT |
|---|---|---|
| Founded | 1981 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 1994 | 2001 |
Fundamental Metrics
Financial Performance| Metric | SKT | CORT |
|---|---|---|
| Price | $36.01 | $34.12 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $37.29 | ★ $105.20 |
| AVG Volume (30 Days) | 1.0M | ★ 1.7M |
| Earning Date | 05-27-2026 | 05-25-2026 |
| Dividend Yield | ★ 3.18% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.71 | ★ 0.82 |
| Revenue | N/A | ★ $761,407,000.00 |
| Revenue This Year | N/A | $29.97 |
| Revenue Next Year | $5.17 | $30.25 |
| P/E Ratio | $51.86 | ★ $41.57 |
| Revenue Growth | N/A | ★ 12.79 |
| 52 Week Low | $28.69 | $28.66 |
| 52 Week High | $37.95 | $117.33 |
Technical Indicators
Market Signals| Indicator | SKT | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 55.81 | 34.22 |
| Support Level | $31.76 | $33.53 |
| Resistance Level | $37.95 | $41.92 |
| Average True Range (ATR) | 0.80 | 2.46 |
| MACD | 0.05 | 0.27 |
| Stochastic Oscillator | 50.51 | 45.15 |
Price Performance
Historical ComparisonAbout SKT Tanger Inc.
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.